Serum free carnitine levels in children with Kawasaki disease

Taichiro Muto1, Nami Nakamura1, Yu Masuda1

  • 1Department of Pediatrics, Aichi Medical University, Aichi, Japan.

Insights

Serum free carnitine (FC) levels were higher in children with Kawasaki disease (KD) who did not respond to treatment. These FC levels also correlated with liver enzymes, suggesting a link between carnitine metabolism and KD severity.

Area of Science:

  • Biochemistry
  • Pediatric Medicine
  • Metabolic Disorders

Background:

  • Carnitine is crucial for fatty acid transport into mitochondria for energy production.
  • Kawasaki disease (KD) is an acute febrile illness affecting children, with unknown precise etiology.
  • No prior studies have investigated carnitine levels in pediatric patients diagnosed with KD.

Purpose of the Study:

  • To characterize serum free carnitine (FC) levels in hospitalized children diagnosed with Kawasaki disease.
  • To explore the relationship between FC levels and treatment response to intravenous immunoglobulin (IVIG).

Main Methods:

  • Retrospective analysis of 45 pediatric patients with KD.
  • Measurement of serum FC levels prior to IVIG administration.
  • Correlation analysis of FC levels with clinical and laboratory parameters, including liver enzymes (AST, ALT) and treatment response.

Main Results:

  • Serum FC levels were significantly higher in non-responders (35.3 μmol/L) compared to responders (31.4 μmol/L) to IVIG.
  • 80% of responders had pre-treatment FC levels below the normal range.
  • Elevated FC levels correlated with higher aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in non-responders.

Conclusions:

  • Elevated serum free carnitine is observed in some children with KD, particularly those refractory to IVIG treatment.
  • FC levels in KD patients show a correlation with AST and ALT levels, indicating a potential link to liver function and disease severity.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
51
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
476
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
291
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
395
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
172
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
75